Golden Throat Holdings Group Company Limited (HKG:6896)
3.730
+0.150 (4.19%)
Apr 24, 2026, 4:08 PM HKT
HKG:6896 Market Cap
HKG:6896 has a market cap or net worth of 2.76 billion as of April 24, 2026. Its market cap has decreased by -8.35% in one year.
Market Cap
2.76B
Enterprise Value
2.31B
Revenue
1.05B
Ranking
n/a
PE Ratio
9.86
Stock Price
3.73
Market Cap Chart
Since July 15, 2015, HKG:6896's market cap has decreased from 3.54B to 2.76B, a decrease of -22.04%. That is a compound annual growth rate of -2.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 2.76B | 22.30% |
| Dec 31, 2025 | 2.25B | -5.86% |
| Dec 31, 2024 | 2.40B | -3.28% |
| Dec 29, 2023 | 2.48B | 75.39% |
| Dec 30, 2022 | 1.41B | 20.89% |
| Dec 31, 2021 | 1.17B | 18.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SSY Group | 6.93B |
| Edding Genor Group Holdings | 6.57B |
| Beijing Tong Ren Tang Chinese Medicine Company | 6.38B |
| Hua Medicine (Shanghai) | 3.54B |
| VISEN Pharmaceuticals | 2.73B |
| Jacobson Pharma Corporation | 2.28B |
| JBM (Healthcare) | 2.12B |
| Essex Bio-Technology | 1.87B |